The effect of single kinetic oscillation stimulation treatment on nonallergic rhinitis

Abstract

Abstract Objective Kinetic oscillation stimulation (KOS) is a new treatment method for nonallergic rhinitis (NAR), usually delivered twice with a 2‐ to 4‐week interval, and thought to stabilize autonomous dysregulation in the nasal mucosa. We aimed to assess the long‐term (1 year) results following one KOS treatment amongst patients with NAR. Methods KOS was administered through a latex balloon placed in the patient's nasal cavity. The balloon is connected to a device that fills the balloon with air pulses, thus vibrating the balloon for 10 min per side. Outcomes were evaluated through patient‐reported outcome measures (Sino‐Nasal Outcome Test 22 [SNOT‐22], Total Nasal Symptom Score [TNSS], Nasal Obstruction Symptom Evaluation [NOSE], and 15D) and measures of patency (rhinomanometry, acoustic rhinometry, peak nasal inspiratory flow [PNIF], and clinical inferior turbinate size). Pre‐treatment actions were repeated at 1, 3, 6, and 12 months. Results In all 49 patients, we found significant improvement in the SNOT‐22, NOSE, and TNSS scores. At 12 months, SNOT‐22 improved from 44 to 34, NOSE from 60 to 45, TNSS from 8 to 7, and PNIF from 80 to 100 L/min (p < .005 for all). We observed no major complications. Conclusion One KOS treatment appears to provide NAR patients with a subjective symptom improvement for at least 1 year, thus possibly decreasing the need for invasive treatment methods. Level of Evidence III.

Keywords

• kinetic oscillation stimulation
• minimally invasive
• nasal congestion
• nonallergic rhinitis
• patient‐reported outcome measures